Naturally induced humoral response against Plasmodium vivax reticulocyte binding protein 2P1

Malaria Journal

卷:20

Wang Nguitragool¹  Jenni Hietanen¹  Anongruk Chim-ong¹  Jetsumon Sattabongkot² 

[1] Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University;

[2] Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University;

关键词: Plasmodium vivax;    Malaria;    Cytophilic;    Complement;    Antibody;    Serology;   

DOI  :  10.1186/s12936-021-03784-1

来源: DOAJ

【 摘 要 】

Abstract Background Plasmodium vivax is the most prevalent malaria parasite in many countries. A better understanding of human immunity to this parasite can provide new insights for vaccine development. Plasmodium vivax Reticulocyte Binding Proteins (RBPs) are key parasite proteins that interact with human proteins during erythrocyte invasion and are targets of the human immune response. The aim of this study is to characterize the human antibody response to RBP2P1, the most recently described member of the RBP family. Methods The levels of total IgG and IgM against RBP2P1 were measured using plasmas from 68 P. vivax malaria patients and 525 villagers in a malarious village of western Thailand. The latter group comprises asymptomatic carriers and healthy uninfected individuals. Subsets of plasma samples were evaluated for anti-RBP2P1 IgG subtypes and complement-fixing activity. Results As age increased, it was found that the level of anti-RBP2P1 IgG increased while the level of IgM decreased. The main anti-RBP2P1 IgG subtypes were IgG1 and IgG3. The IgG3-seropositive rate was higher in asymptomatic carriers than in patients. The higher level of IgG3 was correlated with higher in vitro RBP2P1-mediated complement fixing activity. Conclusions In natural infection, the primary IgG response to RBP2P1 was IgG1 and IgG3. The predominance of these cytophilic subtypes and the elevated level of IgG3 correlating with complement fixing activity, suggest a possible role of anti-RBP2P1 antibodies in immunity against P. vivax.

【 授权许可】

Unknown